A Study to Evaluate the Effectiveness of VIZAMYL™ Reader Training Programme in Europe

Bridging Study With GSK239512 In Patients With Mild To Moderate Alzheimer's Disease

NCT00675090 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies

NCT06815965 ·Status: COMPLETED ·Phase: PHASE2

HT-0712 vs. Placebo in Subjects With Age-Associated Memory Impairment (AAMI)

NCT02013310 ·Status: COMPLETED ·Phase: PHASE2

An Observational Study on Lecanemab Treatment for Early Alzheimer's Disease

NCT07153848 ·Status: RECRUITING

Multi-centre Study of HTL0018318 in Patients as an add-on to Standard-of-care

NCT03456349 ·Status: COMPLETED ·Phase: PHASE1

Prospective Cohort Study of Patients With Early Alzheimer's Disease Treated With Lecanemab

NCT06741553 ·Status: RECRUITING

Safety, Tolerability and Pharmacokinetics of GSK1034702 in Healthy Subjects

NCT00743405 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's Disease

NCT01009255 ·Status: COMPLETED ·Phase: PHASE2

Study of LM11A-31-BHS in Mild-moderate AD Patients

NCT03069014 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)

NCT02079909 ·Status: COMPLETED ·Phase: PHASE2

To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.

NCT00151502 ·Status: COMPLETED ·Phase: PHASE3

Treatment of Language and Memory in Patients With Alzheimer's Disease

NCT00593372 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of the Contribution of Regular Cognitive Exercises to Treatment in Patients With Alzheimer's Disease

NCT03954613 ·Status: UNKNOWN ·Phase: PHASE4

Neuromodulation and Language Acquisition (Stage Ib)

NCT00102856 ·Status: SUSPENDED ·Phase: PHASE4

Efficacy and Safety of T-817MA in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD

NCT04191486 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease

NCT01354691 ·Status: COMPLETED ·Phase: PHASE2

Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-315

NCT00474552 ·Status: TERMINATED ·Phase: PHASE1

A Study in Healthy Men to Test How BI 474121 is Tolerated

NCT04964453 ·Status: COMPLETED ·Phase: PHASE1

Study Evaluating the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of SAM-315 in Healthy Adults

NCT00479440 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Safety, Tolerability and Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies

NCT05225415 ·Status: COMPLETED ·Phase: PHASE2

A Placebo-controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular Dementia

NCT00035191 ·Status: COMPLETED ·Phase: PHASE3

Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's Disease

NCT00501111 ·Status: COMPLETED ·Phase: PHASE2

Parametric Cardiac 18F-flutemetamol PET Imaging in ATTR Cardiomyopathy

NCT05374564 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Alzheimer's Type Who Failed to Benefit From Donepezil

NCT01478633 ·Status: COMPLETED ·Phase: PHASE4

Cognition Platform Study in Participants at Risk for Alzheimer's Disease (AD) (MK-0000-413)

NCT04730635 ·Status: COMPLETED ·Phase: PHASE1